The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.

Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.

The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.

The US FDA has granted 510(k) clearance for Exactech’s Equinoxe Scapula Reconstruction System for acromial and scapular spine fractures.

A Karolinska Institutet-led study has demonstrated that the use of an AI tool can enhance skin cancer diagnosis.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.